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Abstract: The prevalence of food allergy in childhood appears to be increasing in both developed and
transitional countries. The aim of this paper is to review and summarise key findings in the prevention
and management of food allergy, focusing on the role of dietary components and nutritional habits
in the development and optimal functioning of the immune system. Essential fatty acids, zinc
and vitamin D are likely to enhance the anti-inflammatory and antioxidative barrier and promote
immunologic tolerance. Additionally, nutritional components such as pre- and probiotics represent a
novel research approach in the attempt to induce a tolerogenic immune environment. For all these
reasons, the traditional avoidance diet has been, in recent years, completely reconsidered. New
findings on the protective effect of an increased diversity of food introduced in the first year of life on
allergic diseases are consistent with the hypothesis that exposure to a variety of food antigens during
early life might play a role in the development of immune tolerance. Accordingly, therapeutic (and
even preventive) interventions should be planned on an individual basis.
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1. Introduction
Food allergy (FA) represents a substantial health problem in childhood. The prevalence appears
to be increasing in both developed and transitional countries, however a true increase has been
difficult to demonstrate [1]. Over 90% of food allergies are caused by eight common allergens; namely:
eggs, peanuts, cow’s milk, soy, nuts, shellfish, fish, or wheat [2]. On the whole, food allergy affects
approximately 6% of infants younger than three years [2], and prevalence decreases over the first
decade. The cumulative incidence of food hypersensitivity over a 10-year period is 6.7% (95% CI:
5.2–8.4%); 3.0% (95% CI: 1.8–4.2%) had IgE-mediated food allergy and 0.6% (95% CI: 0.07–1.3%) had
non-IgE-mediated food allergy/food intolerance [3]. A systematic review from the European Academy
of Allergy and Clinical Immunology concluded that food allergy prevalence in Europe ranges between
0.1 and 6.0% [4]. The Institute of Medicine report states that the prevalence of food allergies in children
ranges between 1.1 and 10.4% [1]. Food-allergic infants commonly present with symptoms and signs
of atopic eczema, gastrointestinal symptoms and/or recurrent wheezing [5]. Diet plays a crucial role in
both the prevention and management of food allergy. A number of factors, including the maternal diet,
the microbiome and early life feeding, have been investigated for the prevention of allergic diseases [6].
The aim of this paper is to review and summarise key findings in the prevention and management of
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food allergy, with particular reference to nutrients of concern (fats, micronutrients), gut flora (including
the role of pre- and probiotics), early-life feeding and formula choice in cow’s milk allergy.
2. Prevention of Food Allergy: The Role of Nutrition in the Development and Optimal
Functioning of the Immune System
Allergy results when there is a breakdown in normal “tolerance” mechanisms, which leads to
inappropriate and detrimental immune responses to normally harmless substances, including food
allergens such as cow’s milk protein, eggs, nuts, or shellfish [7]. At birth, the immune system is
immature, but it develops with age, antigen stimulation, and appropriate nutrition [8]. In addition,
bacterial colonisation occurs during the first weeks of life, and interactions between intestinal flora
and the developing mucosa result in further development of immune responses and oral tolerance [7].
Nutrition plays a key role in the development, maintenance, and optimal functioning of immune
cells. Nutrients, such as zinc and vitamin D and nutritional factors, such as pre- and probiotics, can
influence the nature of an immune response and are important in ensuring appropriate functioning of
the immune system, as described in the paragraphs below.
2.1. Fat
Appropriate fat intake may become seriously compromised in allergen-restricted diets and may
be further influenced by the “westernized” dietary practices. The role of fat on the immune system
can be divided into the role of saturated vs. unsaturated fats and the particular role of the essential
fatty acids.
2.1.1. Saturated vs. Unsaturated Fats
It has been reported that typical western diets rich in protein and saturated fat and low in complex
carbohydrates may negatively affect the diversity of the gut microbiome [9]. This was supported
by David et al. [10], showing that an animal-based diet high in protein and fat, with very little
fibre intake, resulted in increased abundance of bile-tolerant microorganisms (Alistipes, Bilophila, and
Bacteroides) and decreased levels of Firmicutes that metabolize dietary plant polysaccharides (Roseburia,
Eubacterium rectale, and Ruminococcus bromii) within a five-day period. A recent review also concluded
that the amount, type (e.g., unsaturated vs saturated), and mixture of dietary fats can dramatically
shift gut microbial community membership and function [11]. In addition, high fat, high sugar diets
also affect the gut barrier function in mice, as demonstrated by high horseradish peroxidase (HRP)
influx, lower portal vein endotoxin levels and decreased goblet cell numbers [12]. The gut barrier
function may be permanently affected in non-IgE mediated food allergies, and temporarily affected
during allergen exposure in IgE mediated food allergies [13,14].
2.1.2. Essential Fatty Acids (EFAs)
EFAs are important immune regulators. Linoleic acid (LA), the parental n-6 polyunsaturated
fatty acid (PUFA), is converted into arachidonic acid (AA) by fatty acid elongase and desaturase,
and subsequently may give origin to pro-inflammatory and pro-allergic lipid mediators, whose
collective name is eicosanoids [15]. In contrast, α-linolenic acid (ALA), an n-3 PUFA, is converted
in the mammalian body to eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which
are subsequently converted into anti-inflammatory and/or pro-resolving lipid mediators (such as
resolvins and protectins). EPA forms the precursors of the 3 series of prostaglandins and the 5 series of
leukotrienes, which are biologically less powerful than the corresponding derivatives which form the
n-6 compounds. Because n-3 and n-6 PUFAs compete for the same metabolic pathways, an increase of
n-3 PUFA, parallel to a decrease of n-6 PUFA intake, might theoretically reduce the onset of human
immunologic conditions, including allergies, thanks to the replacement of AA with EPA and DHA in
the membranes of inflammatory cells. EFA, including long-chain PUFAs, may be consumed as part
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of the normal diet through breast milk, formula and food, or as supplements at any stage in the life
cycle [15].
The fatty acid status is of particular concern in infants and children. Essential fatty acids (EFA)
promote the renewal of the protective hydrolipidic film layer of the skin and, accordingly, an altered
EFA metabolism has been associated with the pathogenesis of atopic dermatitis (AD). Moreover,
the clinical spectrum of EFA deficiency may range from mild skin irritation to life-threatening
conditions [16].
In spite of intensive research in the field, a recent systematic review [17] concerning the role of
dietary PUFAs in the development of allergy shows that PUFA supplementation in infancy seems
not to affect infant incidence, childhood incidence or childhood prevalence of food allergy (GRADE
level of evidence: very low; GRADE, Grading of Recommendations Assessment, Development and
Evaluation) in infants up to two years of age, even taking into account a moderate heterogeneity
between studies that reported infant incidence of food allergy (3 studies; 915 infants; RR (risk ratio)
0.81, 95% CI 0.56–1.19%, I2 (fraction of variance due to heterogeneity) = 63%; RD (risk difference)
0.02, 95% CI: 0.06–0.02%, I2 = 74%). However, while well-documented immunomodulatory effects of
n-3 PUFAs (both in vitro and in vivo) highlight the potential role in preventing and treating allergic
disease, larger longitudinal intervention studies are clearly warranted to confirm this observation [18].
2.2. Zinc
Children with food hypersensitivity have increased amounts of mastocytes, eosinophils and
neutrophils in the digestive tract. Persistent exposure to allergen can lead to chronic inflammatory
changes of mucous membrane and increased production of reactive oxygen species (ROS) [19]. Excess
ROS should be neutralized by components of the antioxidative barrier. Therefore, all disturbances
of enzymatic and non-enzymatic mechanisms of this barrier lead to many unfavourable reactions,
including oxidation of cell membrane lipids. Zinc is an essential trace element and it is needed
for various cellular functions; specifically, it is a cofactor of many enzymes, including superoxide
dismutase (SOD), which play an important role in maintaining the oxidative-antioxidative balance. A
study performed in 134 children with food allergy, aged 1 to 36 months, showed that children with
food allergy had significantly lower concentrations of zinc, and therefore a weakened antioxidative
barrier [19]. To our knowledge there are no randomized controlled trials (RCTs) investigating zinc
supplementation and allergic outcomes.
2.3. Vitamin D
The classical role of Vitamin D is, in fact, related to calcium homeostasis and bone health. However,
over the last decade, the effects of vitamin D on the innate and adaptive immune system have been
investigated and expanded [20]. The active form of the vitamin, i.e., 1,25(OH)2D (calcitriol), has
effects on epithelial cells, T cells, B cells, macrophages and dendritic cells. It stimulates innate immune
responses by enhancing the chemotactic and phagocytotic responses of macrophages, as well as the
production of antimicrobial proteins such as cathelicidin. This action plays a role in maintaining
mucosal integrity by stimulating junction genes. Nevertheless, the potential effect of vitamin D on
Th1/Th2 adaptive immune response is of interest and related to food allergy [21–23]. Almost all cells
of the adaptive immune system express the vitamin D receptor, making them also capable of being
vitamin responsive. When specifically considering a potential role for vitamins in food allergy, vitamin
D has been shown to affect several mechanisms that promote immunologic tolerance, including T
regulatory cell function and the induction of tolerogenic dendritic cells. However, clinical trials on
vitamin D supplementation in children and the possible role in preventing food allergy are lacking.
A systematic review of vitamin D supplementation for the prevention of allergic diseases found no
evidences about the protective role of this nutrient in children, but the currently available data are
poor [24].
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2.4. The Role of Prebiotics, Probiotics and Microbiota in the Prevention of Food Allergy
The innate immune system has the ability to modulate adaptive immune responses to food
proteins. Therefore, the type of gastrointestinal microbiota of the newborn and the preservation
of intestinal permeability is crucial for preventing the development of food allergies. The dietary
modulation of nutritional factors through pre-, pro- and synbiotic preparations represent a novel
research hypothesis and a challenge for dietitians and paediatric allergists. The modulation of the
immune system using functional foods is a promising research hypothesis in the attempt to induce a
tolerogenic immune environment [16].
2.4.1. Prebiotics
Prebiotics have been defined as “non-digestible food components that beneficially affect the host
by selectively stimulating the growth and/or activity of one or a limited number of bacteria in the colon
and thereby improving host health”, and recently redefined as “a selectively fermented ingredient that
allows specific changes, both in the composition and/or activity in the gastrointestinal microbiota that
confers benefits” [25]. In December 2016, the panel of experts convened by the International Scientific
Association for Probiotics and Prebiotics (ISAPP) suggested a new definition, i.e., “a substrate that is
selectively utilized by host microorganisms conferring a health benefit” [26]. Based on the body of
available evidence, the Guidelines for Atopic Disease Prevention (GLAD-p) panel concluded that it is
likely that prebiotic supplementation in infants reduces the risk of developing recurrent wheezing and
possibly also the development of food allergy. However, there is very low certainty that there is an
effect of prebiotics on other outcomes, other than an indirect effect due to its effect on the microbiome.
In fact, their activity can be affected by many individual factors, (e.g., host’s microbiota or the genetic
predisposition to diseases). Environmental factors such as diet or antibiotics can also influence the use
of prebiotics [26].
2.4.2. Probiotics
Probiotics are living microorganisms that have been proposed as immune-modulators of the
allergic response by affecting phagocytosis and production of pro-inflammatory cytokines, and thus
have been advocated as therapeutic and preventive interventions for allergic diseases [27]. They
are present in everyday food (not only in yoghurt or fermented milk, but also in cheese—either
hard or soft—and also in less expected sources such as kefir, miso soup or tempeh) and they are a
common exposure in almost everyone’s life [27]. The probiotic effects of complex oligosaccharides in
human milk promote the establishment of a bifidogenic microbiota which, in turn, induces a milieu
of tolerogenic immune responses to foods. Earlier studies suggested a positive effect of probiotic
interventions on atopic dermatitis, but meta-analyses have failed to confirm it.
The new World Allergy Organization (WAO) guidelines determined that it is likely that probiotic
supplementation in infants reduces the risk of developing eczema and suggested that probiotics should
be recommended in mothers of high-risk infants and in infants at high risk of allergic disease, where
“high risk for allergy in a child” is defined as having a biological parent or sibling with an existing or
history of allergic rhinitis, asthma, eczema, or food allergy [27]. The recommendations are conditional,
and based on very low-quality evidence, with no specific recommendation regarding strains, dose,
treatment duration etc.
In terms of tolerance development in those with established food allergy, one study from Australia
performed oral immunotherapy (OIT) to peanut in combination with Lactabillus GG, showing that
89.7% of the study participants in this arm were desensitized to peanut. The authors speculate that this
protective effect may be seen because of the possible effect of the probiotic on T regulatory cells [28].
Further scientific confirmation is required to include probiotics and prebiotics in the therapeutic plans.
Practical implications and how this should be incorporated in advising food allergy sufferers are
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also unclear in terms of advising regular intake of foods high in short-chain fructo-oligo saccharides,
fermented foods and yoghurts.
3. The Role of Allergen Intake and Dietary Diversity in Prevention of Food Allergy
3.1. Allergen Intake
Measures to prevent allergy and food allergy have traditionally included maternal allergen
avoidance during pregnancy and/or lactation, periods of exclusive breast feeding and avoidance
of potential allergens, including food and environmental antigens, during the first year of life and
beyond [29]. The value and significance of food avoidance for preventive purposes has been completely
reconsidered in recent years.
On the contrary, an ideal age to introduce potentially allergenic foods into an infant’s diet has
been debated for the past 2 decades, particularly in high-income countries where allergic disease has
become highly prevalent. Initial approaches to primary prevention of food allergy largely focused
on “avoidance” strategies. In 2000 [30], practice guidelines generally recommended that allergenic
foods (such as egg, cow’s milk, and peanut) be avoided during the first 1 to 3 years of life. As data
accumulated from both observational studies and experimental models, it became apparent that
avoidance practices may not be beneficial.
Given the increasing interest in the role of time of introduction of allergic food into the infant diet
(the so-called “window of opportunity”) and the risk of allergic diseases, intervention trials evaluating
the intake of food, as milk, egg, peanuts, etc., during the first year of life have been performed.
For instance, a recent RCT found no evidence that regular egg intake from age 4 to 6.5 months
substantially alters the risk of egg allergy by age 1 year in infants who are at hereditary risk of allergic
disease and had no eczema symptoms at study entry [31]. These findings are generally supportive
of other data in high-risk patients showing a risk-reducing benefit for early egg introduction, and
risk-reducing benefit for early peanut introduction [32]. The EAT study [33] also showed a reduced risk
in the general population using the per protocol analysis, but not the intention to treat analysis. For
peanut, clinical practice guidelines in the US have incorporated these findings and do recommend early
peanut introduction in the first year of life for high- and standard-risk children [34]. However, despite
some evidence for early introduction of egg, the US guidelines only made recommendations regarding
peanut intake, and concluded that there was not enough evidence to suggest early introduction of
egg. Surprisingly, the UK COT report [35], published very recently, suggested that all foods should
be introduced after a period of exclusive breast feeding from 6 months and that there is no need to
introduce peanut or egg differently from other foods. It seems as if despite the data from recent RCTs
on peanut and egg, the weaning debate will continue, as there is still no consensus about the age
of introduction of these foods. The only consistent messages are: start weaning once the infant is
developmentally ready; don’t delay introduction of allergens: once they are introduced into the diet,
continue to feed them.
3.2. Diet Diversity and Other Related Factors
3.2.1. Dietary Diversity
Recent findings on the protective effect of an increased diversity of food introduced in the first
year of life on allergic diseases (asthma, atopic dermatitis, food allergy and atopic sensitisation) are
consistent with the hypothesis that exposure to a variety of food antigens during early life might be
important for the development of immune tolerance [36–38].
The microbiome plays an important role in ensuring the gut wall integrity and regulation of the
immune system. Diet diversity has been shown to reduce allergic diseases [36,38]. It may well be
that the more diverse diet leads to a more diverse microbiome [39], and that natural microbial load of
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food enhances this process [40]. This in turn may improve the gut wall integrity and regulation of the
immune system, but human trials are needed to confirm this theory.
3.2.2. Food Production
Food production and cooking methods, inclusive of canning, putting food in pouches, producing
“ready to eat” foods, may affect the natural microbioal load of food and hence the immune system as it
may affect the microbiome and, possibly, the allergic response.
Lang et al. [40] reported that the microbial load of different diets (e.g., USA diet vs. vegan diet)
differs due to the foods excluded and cooking methods used. Chaturvedi, et al. [41] reported that the
natural microbial load of fruits and vegetables differ between groups from a different socio-economic
status. In addition, Venter and Maslin reported an association between an increase in baby food sales
and allergic diseases [42], underlining that commercial baby foods are sterile and that the diversity
of ingredients and nutrient content is variable. All these factors highlight that the foods we eat
(irrespective of their nutrient content) may affect the immune system and perhaps development and
management of allergic diseases.
3.2.3. Healthy Diet
It is unclear at present what a “healthy diet” in terms of allergy prevention and management
means, and if a healthy diet as we know it (20% protein, 50% carbohydrate, 30% fat) has any relevance
in allergy prevention. Currently, either the healthy eating index [43] or a Mediterranean-style diet [44]
is being used as a proxy measure for healthy eating. Research using the healthy eating index tool,
specific to the pregnancy diet, found no association between overall healthy eating score and recurrent
wheeze in infants at the age of 3 years [43], and this was confirmed in another study by Moonesinghe et
al. focusing on eating patterns in pregnancy and allergic diseases [45]. In addition to these two studies,
two review papers addressed the issue of the Mediterranean diet on allergy prevention. Venter et al.
summarised studies during pregnancy [46]. Three observational studies have investigated the role of
the Mediterranean diet on allergy outcomes. One study showed a possible increased risk for the infant
to develop allergic disease [47], one showed a reduction in wheeze [48], and another study showed no
effect on allergy prevention [49]. Mediterranean style eating patterns shows more promising effects
with reduction in asthma/wheezing symptoms seen but no effect on other allergic symptoms [44].
More studies are therefore needed with well-defined criteria for healthy eating to study its effect on
allergy prevention.
3.2.4. Other Factors
More recently, the role of advanced glycosylated end products in food and the direct effect on
the Th2 immune system and the microbiome has been described [50]. One mouse model study also
questioned the role of emulsifiers on the gut microbiome. This study showed that a diet high in
emulsifiers destroyed the epithelial mucous layer in the gut, altered gut microbial composition and
promoted inflammation [51].
4. The Role of Diet in the Management of Food Allergy
The cornerstone of the nutritional management of food allergies is an individualized allergen
avoidance management plan. In children, the main goals are to prevent the occurrence of acute and
chronic symptoms by avoiding the offending food(s), whilst providing an adequate, healthy and
nutritionally balanced diet and maintaining optimal growth; ideally, under the guidance of a trained
dietitian [52]. Complete avoidance of the allergen is still required by some, but latest developments
in food allergy have indicated that some individuals with food allergies tolerate baked forms of milk
and egg [53]. Additionally, complete avoidance of all nuts is not necessarily recommended anymore,
and only those nuts reacted to should be eliminated from the diet [54]. In addition to nutritional
consequences of food allergy, it is known that children and families with food allergies experience a
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decreased quality of life across a number of domains, which can create anxiety and lead to avoidance
of social situations [55–58]. Hence, it is suggested that liberalisation of the diet, when appropriate and
safe, will increase both quality of life and nutritional intake.
4.1. Cow’s Milk Allergy
Exclusion of any food group can result in a nutritionally deficient diet, but the elimination of milk
and products in infancy is particularly likely to cause nutritional deficiencies [59] and deserves special
emphasis. Cow’s milk proteins (CM) are among the first foods introduced into an infant’s diet, and
accordingly they represent one of the first and most common causes of food allergy in early childhood.
Cow’s milk allergy generally requires a strict exclusion diet, usually for the first year of life. This
exclusion of a main food group occurs at a critical time in the development of food preferences and
eating habits. The management of CMA (cow’s milk allergy) in infants and young children requires
individualized advice regarding avoidance of cow’s milk, including advice to breastfeeding mothers
and/or guidance on the most appropriate specialized formula or milk substitute [60]. In many cases,
micronutrient supplements will also be required; however, their usage is not always intuitive with
both under- and over-supplementation occurring [61].
Cow’s milk proteins could induce an allergic reaction: in particular beta-lactoglobulin (BLG),
included in the whey fraction, is not present in human milk, and is therefore is considered the principal
component involved in the etiology of the disease. During the production of infant formula, only the
processes of extensive hydrolysis, ultrafiltration or an enzymatic cleavage result in truly hypoallergenic
formulas [16].
4.1.1. Choice of Formula in CMA
The nutritional value of a milk substitute must be taken into account at ages lower than 2 years
of life, when such a type of food is needed and may represent the only source of nutrients in
the first months of life [16]. As breast milk composition differs both in component ratios and
structure from other milks, the composition of infant formula should serve to meet the particular
nutritional requirements and to promote normal growth and development of the infants for whom
they are intended [62,63]. When a replacement formula is needed, allergologists can avail themselves
of different types of formula [64]. The alternative formulas considered for CMA are extensively
hydrolysed whey or casein formula (eHWF or eHCF), and amino acid-based formula (AAF), which
are considered to be of low antigenic potential and are therefore preferred in highly allergic children.
The unpalatable taste of hydrolysed formulas has often been associated with reduced intakes and
a consequent growth faltering in infants fed these types of formula, particularly in the first year of
life [59].
In recent years, an alternative explanation has been proposed based on the content of free amino
acids (FAAs) in hydrolysed formulas, added to complete their biologic value. Glutamic acid, in
particular, has been suggested to downregulate appetite during feeding by interacting with specific
receptors in the oral cavity and gastrointestinal tract. However recent studies have shown no negative
effect of feeding AA formulas in infants; on the contrary, they may be beneficial for growth [65].
Other studies have demonstrated that dietary management with extensively hydrolysed
casein-based formula (eHCF) supplemented with the probiotic Lactobacillus rhamnosus GG (LGG)
results in a higher rate of tolerance acquisition in infants with CMA than in those treated with
eHCF without supplementation or with other non-casein-based formulas. The mechanistic basis
for this effect could be the possible influence of eHCF+LGG on the strain-level bacterial community
structure of the infant gut [66]. However, randomised controlled trials to date have not yielded
sufficient evidence to recommend probiotics for the primary prevention of allergic disorders. Indeed,
the Nutrition Committee of the European Society for Paediatric Gastroenterology Hepatology and
Nutrition (ESPGHAN) does not support routine supplementing with probiotics in infant formulas [67].
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Soy protein-based formula may be an option in infants older than 6 months who do not accept
the bitter taste of an eHCF, or in cases in which the higher cost of an eHCF is a limiting factor [68].
However, soy formulae have nutritional disadvantages. Absorption of minerals and trace elements
may be lower because of their phytate content. They also contain appreciable amounts of isoflavones,
with a potentially weak estrogenic action that can lead to high serum concentrations in infants. Also,
the possible derivation from genetically modified soy should be considered. Hence, the European
Society of Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) and the American
Academy of Pediatrics (AAP) recommend that cow’s-milk-based formulas should be preferred over
soy formulas in healthy infants, and soy protein-based formulas should not usually be used during
the first 6 months of life [68].
Other mammal’s milks, those of, goats, ewes, mares, donkeys, or camels, have been proposed
as substitutes in the management of CMA in infants and children, but are NOT recommended, due
to either nutritional issues, cross-reactions or both. The Diagnosis and Rationale for Action against
Cow’s Milk Allergy (DRACMA) guidelines state that milk allergens of various mammalian species
cross-react [16]. The greatest homology is found between cow’s, buffalo’s, sheep’s and goat’s milk
proteins. Proteins in their milks have less structural similarity with pig, horse, donkey, camel and
dromedary. Goat’s, buffalo’s and ewe’s milk are particularly not recommended by the World Allergy
Organization due to cross-reactivity with cow’s milk [16]. The tolerance of other mammalian milks
needs to be further investigated in clinical trials, and there are some concerns about their chemical
composition and sanitation. In conclusion, either amino acid-based formulas or eHCFrepresent the
most available solutions for allergic infants who are no longer breast-fed. The therapeutic interventions
should therefore be indicated on an individual basis.
5. Conclusions
Food allergy represents a significant health burden at either an individual and population level
worldwide. Recent guidelines for the prevention of food allergies advocate that there is no need to
delay the introduction of allergenic foods once weaning has commenced. In terms of food allergy
management (end even prevention), individualised strategies should be implemented. These strategies
will include developmental readiness to be weaned, prevalence of particular food allergies in certain
countries, family eating patterns and availability of physician and dietetic care.
Care should be taken to ensure adequate intake of nutrients, particularly in relation to cow’s milk
allergy, when selecting a suitable hypoallergenic formula. There is emerging evidence regarding the
role of fats (particularly EFAs), pre-/probiotics, commercial foods, healthy eating and micronutrients
on food allergy. A better understanding of how nutrients and other aspects of food, food patterns and
food preparation may affect the immune system and allergy outcomes is required to best advise those
at risk of developing food allergies and those with current food allergies.
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